Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizProblems presented by the backlog of unexamined patent applications
By Lawrence B. Ebert, Esq.
For better or for worse, investors are not always able to make their own independent judgments with respect to the quality of an underlying technology that is the basis for a start-up company. What this means is that investors typically look for other ways to gauge whether the underlying technology is sound, including looking to the United States Patent Office for some kind of independent verification from a neutral party regarding the merits of the technology. While the Patent Office cannot and does not vouch for commercial feasibility, when you obtain a patent it should be at least some evidence that the technology or innovation included in the application is unique to some level, at least based on the references that could reasonably be obtained with a competent patent search.
This is one reason we want the Patent Office to do a credible job in examining applications. Another reason is simply to have a database of valuable information, so that anybody (venture capitalist or other) can go to the file of issued patents and have a reasonable expectation of finding things that are useful, novel, and nonobvious. The Lemley approach of "rational ignorance" gives no value to the societal benefit of having a trustworthy repository.
See also
http://ipbiz.blogspot.com/2009/03/worse-than-plagiarism.html
http://ipbiz.blogspot.com/2007/03/more-arguments-against-rational.html
Full post as published by IPBiz on April 23, 2009 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Federal Government
Florida residents sue claiming extraordinary delays in judging citizenship applications.
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
FenPhen
Serious Heart Problems Found In Ex-Users

L.A. announces plan to reduce backlog of unexamined DNA evidence from violent crimes
Peer to Patent Review Program Update
Another Modest Proposal on Reducing the Backlog of Pending Patent Applications
US Debates Patent Exam Deferrals; Patent Reform Bill Expected This Year









